Literature DB >> 1000139

Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity.

H M Van Praag, J Korf, L C Dols.   

Abstract

The chemical structure of a neuroleptic does not relaibly predict the exact profile of its therapeutic action. We considered the question whether the biochemical action of a neuroleptic, and specifically the ratio between DA-receptor block and NA-receptor block, might have a higher predictive value in this respect. In this context we carried out a double-blind study of the therapeutic value of clozapine and perphenazine in acute psychoses of varying symptomatology anc aetiology. There are strong indications that clozapine has only a slight inhibitory effect on transmission in central DA-ergic neurons, but markedly inhibits transmission in central NA-ergic neurons, and that the reverse applies to perphenazine. In view of these data we expected perphenazine to be a stronger antipsychotic and a weaker sedative than clozapine, and vice versa. The plausibility of this hypothesis was demonstrated. Partly also on the basis of earlier research, we concluded that the biochemical action of a neuroleptic is a more faithful predictor of its therapeutic action profile than the chemical structure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000139     DOI: 10.1192/bjp.129.6.547

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

1.  Neurochemical and psychoanalytical approaches to mania.

Authors:  J C Cookson; T Silverstone
Journal:  Proc R Soc Med       Date:  1977

2.  Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.

Authors:  L Bjerkenstedt; B Gullberg; C Härnryd; G Sedvall
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979

3.  Typical and atypical neuroleptics are potent antagonists at alpha 1-adrenoceptors of the dorsal lateral geniculate nucleus. An electrophysiological study.

Authors:  J Marwaha; G K Aghajanian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

Review 4.  Perphenazine for schizophrenia.

Authors:  Benno Hartung; Stephanie Sampson; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

Review 5.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Effects of clozapine on CSF homovanillic acid in spasmodic torticollis.

Authors:  A Thiel; D Dressler; A Reimer; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 7.  Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.

Authors:  André R Brunoni; Laura Tadini; Felipe Fregni
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

8.  Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine.

Authors:  R S Kahn; L Siever; M Davidson; C Greenwald; C Moore
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.

Authors:  H Y Meltzer; R G Fessler; V S Fang
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

Review 10.  Clozapine: neuroleptic-induced EPS and tardive dyskinesia.

Authors:  D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.